Mount Sinai’s Scott Scheinin, MD, and Harish Seethamraju, MD, are establishing the End-Stage Lung Disease and Transplant Program as a leader in treating complex cases. As of December 2022, they had completed 14 transplantations, including six double lung transplants and eight single transplants.
